Azenta Announces Acquisition Of Gene Library Maker SynPlexity, Exclusive License With Elegen For DNA Synthesis Technology; Terms Not Disclosed
Share
Why It Matters
Azenta bought a company called SynPlexity that makes gene libraries. This means Azenta is growing its biology tools business and betting on DNA work.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.